Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance to Provide Scrapie Genotyping in Greece

NEW YORK, Aug. 11 (GenomeWeb News) - Genaissance Pharmaceuticals will provide scrapie genotyping services to Antisel A. Selidis of Greece, a contractor for the Greek government, Genaissance said today.


Under the agreement, Genaissance will be the exclusive genotyping provider for Antisel, which has been awarded a contract by the Hellenic Ministry of Rural Development and Food. The contract derives from a European Union mandate to establish a breeding program in sheep that confers resistance to scrapie.


Antisel is Genaissance's distributor in Greece, Bulgaria, and the former Yugoslav Republic of Macedonia.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.